ArticleJournal of immunology (Baltimore, Md. : 1950)2012

Broad cross-presentation of the hematopoietically derived PR1 antigen on solid tumors leads to susceptibility to PR1-targeted immunotherapy.

Gheath Alatrash et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.